Providencia Rettgeri Common Causes of UTI

Main Article Content

Abdulla Riyadh Abdullhamzah
Oras Sattar Numea
Ahmed Madeeh Khalil
Hussein Naeem Mohammed
Muroj Arheem Esmaein
Sarah Hekmat Abdul Amir
Ahmed Kazem Almeer

Abstract

Wasit city, Iraq provided a total of twenty-four different samples of urine for the researchers to examine. The samples were first cultured onto Ma-Cconkey agar and Blood agar, and placed into brain heart infusion broth. Microscopic inspection, cultural characteristics, biochemical assays, and the Api20 E system were all utilized to independently verify the isolates' identities. Only two out of twenty-four human samples (8.3%) included Providencia species, with P. rettgeri being the most prevalent of those species. Using the disc diffusion technique, tests of antimicrobial susceptibility were carried out against 10 different antibiotics. All of the Providencia isolates had evidence of multidrug resistance (MDR), and the level of absolute resistance to cefoxitin, methicillin, vancomycin, doxycycline, clarithromycin, and trimethoprim/sulfamethoxazole was 100%. They exhibited a high degree of sensitivity to ofloxacin, chloramphenicol, cefixime, and teimethoprim, with a percentage of 100%.

Article Details

How to Cite
Abdullhamzah, A. R. ., Oras Sattar Numea, Ahmed Madeeh Khalil, Mohammed, H. N. ., Muroj Arheem Esmaein, Sarah Hekmat Abdul Amir, & Ahmed Kazem Almeer. (2023). Providencia Rettgeri Common Causes of UTI. International Journal of Medical Science and Clinical Research Studies, 3(4), 727–730. https://doi.org/10.47191/ijmscrs/v3-i4-28
Section
Articles

References

I. O'Hara, C. M., Brenner, F. W., & Miller, J. M. (2000). Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clinical microbiology reviews, 13(4), 534-546.

II. Choi, H. K., Kim, Y. K., Kim, H. Y., Park, J. E., & Uh, Y. (2015). Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital. The Korean journal of internal medicine, 30(2), 219-225.

III. Sharma, D., Sharma, P., & Soni, P. (2017). First case report of Providencia rettgeri neonatal sepsis. BMC research notes, 10(1), 1-3.

IV. Rajni, E., Jain, A., Garg, V. K., Sharma, R., Vohra, R., & Jain, S. S. (2022). Providencia Causing UTIs: Are We Reaching a Dead End. Indian J Crit Care Med, 26(4), 446-451.

V. Sagar, S., Narasimhaswamy, N., & d’Souza, J. (2017). Providencia rettgeri: an emerging nosocomial uropathogen in an indwelling urinary catheterised patient. Journal of clinical and diagnostic research: JCDR, 11(6), DD01.

VI. Maiti, T. K., Pandey, P., & Singh, V. K. (2013). Providencia rettgeri: an unusual cause of central nervous system infections. The American journal of the medical sciences, 346(2), 158-159.

VII. Sharma, S., Bora, P., Singla, N., Gupta, V., & Chander, J. (2021). Isolation of Morganella morganii and Providencia species from clinical samples in a tertiary care hospital in North India. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 21(1), 84-89.

VIII. Abdallah, M., & Balshi, A. (2018). First literature review of carbapenem-resistant Providencia. New Microbes New Infect 25: 16–23.

IX. Mataseje, L. F., Boyd, D. A., Lefebvre, B., Bryce, E., Embree, J., Gravel, D., ... & Wong, A. (2014). Complete sequences of a novel bla NDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada. Journal of Antimicrobial Chemotherapy, 69(3), 637-642.

X. Tada, T., Miyoshi-Akiyama, T., Dahal, R. K., Sah, M. K., Ohara, H., Shimada, K., ... & Pokhrel, B. M. (2014). NDM-1 Metallo-β-Lactamase and ArmA 16S rRNA methylase producing Providencia rettgeri clinical isolates in Nepal. BMC infectious diseases, 14, 1-5.

XI. Shin, S., Jeong, S. H., Lee, H., Hong, J. S., Park, M. J., & Song, W. (2018). Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum β-lactamase causing a first outbreak in Korea. Annals of clinical microbiology and antimicrobials, 17, 1-6.

XII. Clinical and Laboratory Standards Institute (2019). Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI

XIII. European Committee on Antimicrobial Susceptibility Testing (EUCAST).(2020). Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0.

XIV. Krumperman, P. H. (1983). Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Applied and environmental microbiology, 46(1): 165-170.

XV. Magiorakos , A. P., Srinivasan, A., Carey, R. T., Carmeli, Y., Falagas, M. T., Giske, C. T., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson- Liljequist, B., Paterson, D. L., Rice, L. B., Stelling, J., Struelens, M. J., Vatopoulos, A., Weber J. T. and Monnet, D. T. (2012). Multidrug- resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection, 18(3): 268-281.

XVI. Jasim, I. M. Dr. Rasmiya A.(2015). patients with Urinary tract infections. International Journal,20(4):11

XVII. Procop, G. W., Church, D. L., Hall, G. S. and Janda, W. M. (2017).7th ed. Koneman's Color Atlas and Textbook of Diagnostic. Philadelphia: Wolters Kluwer ;Pp: 845-853.

XVIII. Somvanshi, V. S., Lang, E., Sträubler, B., Spröer, C., Schumann, P., Ganguly, S., Saxena, A. K. and Stackebrandt, E. (2006). Providencia vermicola sp. nov., isolated from infective juveniles of the entomopathogenic nematode Steinernema thermophilum. International Journal of Systematic and Evolutionary Microbiology, 56(3): 629-633.

XIX. Khunthongpan, S., Sumpavapol, P. and Tanasupawat, S. (2013). Providencia thailandensis sp. nov., isolated from seafood processing wastewater. The Journal of general and applied microbiology, 59(3): 185- 190.

XX. Denton, M. (2007). Enterobacteriaceae. International journal of antimicrobial agents, 29: 9-22.

XXI. Olaitan, A. O., Diene, S. M., Assous, M. V. and Rolain, J. M. (2016). Genomic plasticity of multidrug-resistant NDM-1 positive clinical isolate of Providencia rettgeri. Genome biology and evolution, 8(3): 723-728.

XXII. Cao, J., Li, M., Xu, C., Zhou, T., Du, J., Sun, Y., Qin, L. and Xu, J. (2017). Characterization of Integrons and qnr Genes in Proteeae from a Teaching Hospital in China. Chemotherapy, 62(1): 12-18.

XXIII. Al‐Gburi, N. M. (2020). Isolation and Molecular Identification and Antimicrobial Susceptibility of Providencia spp. from Raw Cow’s Milk in Baghdad, Iraq. Veterinary Medicine International, 2020:1-6.

XXIV. Al-Janabi .H.S. (2012). Immunopathological Study of Providencia rettgeri isolated from urinary tract infections in Babylon province. Msc. Thesis in Microbiology . University of Babylon . Babylon – Iraq.